We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+14.19%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$117B
AUM Growth
+$9.87B
(+9.2%)
Cap. Flow
-$1.11B
Cap. Flow
% of AUM
-0.95%
Top 10 Holdings %
Top 10 Hldgs %
30.52%
Holding
4,391
New
216
Increased
2,182
Reduced
1,537
Closed
202
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital One
COF
|
+$89.2M |
| 2 |
Flutter Entertainment
FLUT
|
+$43.9M |
| 3 |
Okta
OKTA
|
+$32.1M |
| 4 |
Chewy
CHWY
|
+$31.8M |
| 5 |
Coinbase
COIN
|
+$26.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFS
Discover Financial Services
DFS
|
+$91M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$75.5M |
| 3 |
Amazon
AMZN
|
+$71.7M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$71.5M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$68.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.83% |
| 2 | Financials | 13.86% |
| 3 | Consumer Discretionary | 10.91% |
| 4 | Healthcare | 9.41% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Rocky Brands
RCKY
$353M
| $247K | ﹤0.01% |
11,133
+280
| +3% | +$5.33K |
|
2902
4D Molecular Therapeutics
FDMT
$609M
| $245K | ﹤0.01% |
65,958
-4,845
| -7% | -$17K |
|
2903
Definitive Healthcare
DH
$68.4M
| $245K | ﹤0.01% |
62,705
-13,923
| -18% | -$43.9K |
|
2904
Enanta Pharmaceuticals
ENTA
$391M
| $244K | ﹤0.01% |
32,308
+1,168
| +4% | +$7.03K |
|
2905
Johnson Outdoors
JOUT
$512M
| $244K | ﹤0.01% |
8,066
+289
| +4% | +$7.56K |
|
2906
iShares MSCI Netherlands ETF
EWN
$735M
| $244K | ﹤0.01% |
4,478
| – | – |
|
2907
Benitec Biopharma
BNTC
$431M
| $244K | ﹤0.01% |
20,858
+20,672
| +11,114% | +$289K |
|
2908
Ranpak Holdings
PACK
$479M
| $244K | ﹤0.01% |
68,253
+625
| +0.9% | +$2.32K |
|
2909
Kingstone Companies
KINS
$282M
| $243K | ﹤0.01% |
+15,781
| New | +$262K |
|
2910
Prime Medicine
PRME
$575M
| $242K | ﹤0.01% |
97,972
+16,072
| +20% | +$24.8K |
|
2911
The Joint Corp
JYNT
$119M
| $242K | ﹤0.01% |
20,934
+4,307
| +26% | +$46.1K |
|
2912
LCNB Corp
LCNB
$285M
| $241K | ﹤0.01% |
16,605
+4,685
| +39% | +$67.9K |
|
2913
Smith & Nephew
SNN
$12.6B
| $240K | ﹤0.01% |
7,849
-3,617
| -32% | -$102K |
|
2914
DMC Global
BOOM
$153M
| $240K | ﹤0.01% |
29,827
-349
| -1% | -$2.47K |
|
2915
Arq
ARQ
$99.6M
| $240K | ﹤0.01% |
44,607
+17,688
| +66% | +$77.4K |
|
|
SMC
2916
Summit Midstream
SMC
$480M
| $239K | ﹤0.01% |
+9,734
| New | +$267K |
|
2917
Manulife Financial
MFC
$72.9B
| $238K | ﹤0.01% |
7,458
-1,179
| -14% | -$36.3K |
|
2918
MediWound
MDWD
$174M
| $238K | ﹤0.01% |
12,304
+988
| +9% | +$18.6K |
|
2919
Hawthorn Bancshares
HWBK
$277M
| $238K | ﹤0.01% |
+8,177
| New | +$236K |
|
2920
Allogene Therapeutics
ALLO
$683M
| $237K | ﹤0.01% |
209,336
+25,628
| +14% | +$34.1K |
|
2921
DocGo
DCGO
$64.5M
| $236K | ﹤0.01% |
150,272
+5,795
| +4% | +$10.8K |
|
2922
Electromed
ELMD
$352M
| $236K | ﹤0.01% |
+10,721
| New | +$233K |
|
2923
OneWater Marine
ONEW
$203M
| $236K | ﹤0.01% |
17,590
-1,206
| -6% | -$17.1K |
|
2924
Flexsteel Industries
FLXS
$303M
| $236K | ﹤0.01% |
6,537
-1,251
| -16% | -$41.4K |
|
2925
Funko
FNKO
$335M
| $235K | ﹤0.01% |
49,431
+3,697
| +8% | +$16.9K |
|
Similar funds
RhumbLine Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, RhumbLine Advisers held 4,391 positions worth $117B, up 9.2% from $107B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
RhumbLine Advisers's Q2 2025 filing shows 216 new, 2,182 increased, 1,537 reduced and 202 closed positions. Its largest new stake was Ralliant Corp: 320,982 shares worth $15.6M. The largest sale was Discover Financial Services, an estimated $91M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q2 2025 buy was Ralliant Corp: 320,982 shares worth $15.6M.
- RhumbLine Advisers added most to Capital One in Q2 2025, an estimated $89.2M increase.
- RhumbLine Advisers's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $75.5M.
- RhumbLine Advisers fully exited Discover Financial Services in Q2 2025, selling an estimated $91M.
- RhumbLine Advisers's ten largest holdings make up 31% of its $117B portfolio in Q2 2025.
- RhumbLine Advisers opened 216 new positions and closed 202 in Q2 2025.
- RhumbLine Advisers's portfolio value rose 9.2% quarter-over-quarter to $117B.
Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.